Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

New Insights From An Old Drug: Carbenoxolone, Huntington’s Disease And Alcoholism

This article was originally published in Start Up

Executive Summary

The old and little used gastritis and ulcer drug carbenoxolone is now being developed as a Huntington’s disease treatment. New research also hints at a role for it in treating alcohol abuse.



Related Companies